← Eichor
Condition: Neuroendocrine Tumor Grade 2 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Neuroendocrine Tumor Grade 2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CapTemY90 for Grade 2/3 NET Liver Metastases
Phase 2 · 4 location(s) · Abramson Cancer Center at Penn Medicine · NCT04339036Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and
Phase 2 · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT07016230Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Phase 3 · 65 location(s) · Novartis Pharmaceuticals · NCT06784752Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for
Phase 1 · 1 location(s) · Stanford University · NCT04609592Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT04464122Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
Phase 2/Phase 3 · 1 location(s) · The Netherlands Cancer Institute · NCT06855095Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
NA · 1 location(s) · Emory University · NCT04278118Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410494Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma
NA · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT07564570177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
Phase 2 · 1 location(s) · University of Iowa · NCT06395402Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)
Phase 2 · 2 location(s) · Washington University School of Medicine · NCT06926634FTT PET/CT in Pancreatic Neuroendocrine Tumors
Phase 1 · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT07114939Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Phase 2 · 2 location(s) · AC Camargo Cancer Center · NCT06472388Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06161532Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not
NA · 4 location(s) · Uppsala University · NCT07273409Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
Phase 2 · 12 location(s) · Australasian Gastro-Intestinal Trials Group · NCT06345079
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.